Tech Company Financing Transactions
Imbed Biosciences Funding Round
Private investors participated in a $1.1 million venture round for Imbed Biosciences. The round closed on 10/31/2018.
Transaction Overview
Company Name
Announced On
10/31/2018
Transaction Type
Venture Equity
Amount
$1,055,120
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 14 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5520 Nobel Dr. 100
Fitchburg, WI 53711
USA
Fitchburg, WI 53711
USA
Phone
Website
Email Address
Overview
Imbed's vision is to develop next-generation medical devices that can reduce patient pain and costs for management of burns, chronic wounds, hernia meshes, gastro-intestinal defects, and dural membranes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ankit Agarwal
Co-Founder
Nicholas Abbott
Co-Founder
Charles Czuprynski
Co-Founder
Jonathan McAnulty
Co-Founder
Christopher Murphy
Co-Founder
Michael Schurr
VP - Bus. Development
Gary Robinson
VP - Product Management
Jeffrey Dalsin
VP - R & D
Gaurav Pranami
Browse more venture capital transactions:
Prev: 10/31/2018: Freebird venture capital transaction
Next: 10/31/2018: Terns Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs